Multiple myeloma is preceded by two precursor states known as monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). The field of precursor conditions of myeloma is evolving; trials are now investigating the potential for identifying and treating high-risk patients who could benefit from therapeutic intervention that may ultimately delay or even prevent their progression to myeloma.
During this event, our faculty will:
- Discuss the background on precursor conditions and who may have higher risk of progression to myeloma
- Describe the ongoing clinical trials in precursor conditions for high risk patients
- Explain early identification and monitoring
- Answer your submitted questions related to precursor conditions
THANK YOU TO OUR SPONSORS